Bellevue Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Buy
1,373
+3
+0.2% +$699 0.16% 61
2026
Q1
$335K Sell
1,370
-197
-13% -$45.9K 0.17% 59
2025
Q4
$324K Buy
1,567
+4
+0.3% +$791 0.1% 60
2025
Q3
$290K Buy
1,563
+3
+0.2% +$514 0.13% 62
2025
Q2
$238K Buy
1,560
+5
+0.3% +$769 0.12% 64
2025
Q1
$258K Buy
1,555
+4
+0.3% +$626 0.14% 60
2024
Q4
$224K Buy
1,551
+33
+2% +$5.11K 0.12% 65
2024
Q3
$246K Buy
1,518
+2
+0.1% +$319 0.13% 60
2024
Q2
$222K Sell
1,516
-125
-8% -$18.6K 0.12% 63
2024
Q1
$260K Buy
1,641
+3
+0.2% +$478 0.15% 58
2023
Q4
$257K Buy
1,638
+2
+0.1% +$307 0.23% 57
2023
Q3
$255K Buy
1,636
+3
+0.2% +$495 0.17% 48
2023
Q2
$270K Sell
1,633
-8
-0.5% -$1.29K 0.17% 48
2023
Q1
$254K Buy
1,641
+3
+0.2% +$484 0.17% 49
2022
Q4
$288K Buy
1,638
+1
+0.1% +$173 0.22% 42
2022
Q3
$266K Buy
1,637
+3
+0.2% +$508 0.21% 48
2022
Q2
$291K Buy
1,634
+2
+0.1% +$356 0.21% 48
2022
Q1
$293K Buy
1,632
+2
+0.1% +$340 0.18% 52
2021
Q4
$279K Sell
1,630
-61
-4% -$9.99K 0.16% 59
2021
Q3
$276K Buy
1,691
+2
+0.1% +$341 0.17% 59
2021
Q2
$278K Sell
1,689
-70
-4% -$11.6K 0.17% 60
2021
Q1
$290K Buy
1,759
+1
+0.1% +$162 0.18% 59
2020
Q4
$301K Sell
1,758
-49
-3% -$7.23K 0.18% 53
2020
Q3
$269K Sell
1,807
-600
-25% -$88.8K 0.19% 55
2020
Q2
$338K Sell
2,407
-1,642
-41% -$239K 0.35% 50
2020
Q1
$627K Buy
4,049
+130
+3% +$18.4K 0.65% 33
2019
Q4
$572K Buy
+3,919
New +$532K 0.44% 38

Other funds holding JNJ

Bellevue Asset Management's JNJ Position: Q2 2026 in Review

Bellevue Asset Management increased its Johnson & Johnson (JNJ) stake by 0.22% in Q2 2026, buying an estimated $699 and bringing the position to 1,373 shares worth $349K. The position accounts for 0.16% of the portfolio, ranked #61.

Bellevue Asset Management first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $627K in Q1 2020. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bellevue Asset Management held 1,373 shares of Johnson & Johnson worth $349K as of Q2 2026.
  • Bellevue Asset Management bought 3 Johnson & Johnson shares in Q2 2026, an estimated $699.
  • Johnson & Johnson made up 0.16% of Bellevue Asset Management's portfolio in Q2 2026, its #61 holding.
  • Bellevue Asset Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • Bellevue Asset Management's Johnson & Johnson position peaked at $627K in Q1 2020.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.